0000950170-24-012894.txt : 20240208
0000950170-24-012894.hdr.sgml : 20240208
20240208171727
ACCESSION NUMBER: 0000950170-24-012894
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231023
FILED AS OF DATE: 20240208
DATE AS OF CHANGE: 20240208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ESGEN LLC
CENTRAL INDEX KEY: 0001865514
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40927
FILM NUMBER: 24610185
BUSINESS ADDRESS:
STREET 1: 5956 SHERRY LANE, SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75225
BUSINESS PHONE: 214-987-6100
MAIL ADDRESS:
STREET 1: 5956 SHERRY LANE, SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75225
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ESGEN Acquisition Corp
CENTRAL INDEX KEY: 0001865506
STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
ORGANIZATION NAME: 04 Manufacturing
IRS NUMBER: 981601409
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5956 SHERRY LANE, SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75225
BUSINESS PHONE: 214-987-6100
MAIL ADDRESS:
STREET 1: 5956 SHERRY LANE, SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75225
4
1
ownership.xml
4
X0508
4
2023-10-23
0001865506
ESGEN Acquisition Corp
ESAC
0001865514
ESGEN LLC
5956 SHERRY LANE
SUITE 1400
DALLAS
TX
75225
false
false
true
false
false
Class A Ordinary Shares
2023-10-23
4
C
false
5619077
A
5619077
D
Class B Ordinary Shares
2023-10-23
4
C
false
5619077
D
Class A Ordinary Shares
5619077
0
D
As described in the Issuer's registration statement on Form S-1 (File No. 333-259836) under the heading "Description of Securities-Founder Shares", the Class B ordinary shares, par value $0.0001 per share, will automatically convert into Class A ordinary shares, par value $0.0001 per share, of the Issuer at the time of the Issuer's initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date.
(continued from footnote 1) At an extraordinary general meeting of the Issuer's shareholders held on October 20, 2023, among other things, the Issuer's Amended and Restated Memorandum and Articles of Association was amended to change certain provisions which restrict the Class B ordinary shares from converting to Class A ordinary shares prior to the consummation of an initial business combination (the "Conversion Amendment"). In connection with the approval of the Conversion Amendment at the meeting, the Reporting Person converted all of its 5,619,077 Class B ordinary shares into an equal number of Class A ordinary shares.
/s/ Andrejka Bernatova, as attorney-in-fact
2024-02-08